Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
350.00
-13.4 (-3.69%)
BSENSE

Jun 11, 04:01 PM

BSE+NSE Vol: 1.28 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
944.01
819.81
806.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
944.01
819.81
806.67
Raw Material Cost
425.33
344.20
331.26
Purchase of Finished goods
64.71
55.41
58.06
(Increase) / Decrease In Stocks
-68.86
-24.91
0.57
Employee Cost
151.68
127.19
109.63
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
219.81
181.82
161.26
Total Expenditure (Excl Depreciation)
792.67
683.71
660.79
Operating Profit (PBDIT) excl Other Income
151.34
136.10
145.88
Other Income
2.66
3.63
2.18
Operating Profit (PBDIT)
154.00
139.73
148.06
Interest
36.61
24.52
15.36
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
117.39
115.21
132.70
Depreciation
30.83
21.06
17.02
Profit Before Tax
86.55
94.14
115.67
Tax
22.34
24.49
29.54
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
64.21
69.65
86.14
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
64.21
69.65
86.14
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
64.21
69.65
86.14
Equity Capital
10.03
10.03
10.03
Face Value
1.0
1.0
1.0
Reserves
654.92
591.05
522.53
Earnings per share (EPS)
6.4
6.94
8.59
Diluted Earnings per share
6.4
6.95
8.74
Operating Profit Margin (Excl OI)
16.03%
16.6%
18.08%
Gross Profit Margin
12.44%
14.05%
16.45%
PAT Margin
6.8%
8.5%
10.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 15.15% vs 1.63% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -7.81% vs -19.14% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.20% vs -6.70% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 49.31% vs 59.64% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Gufic BioScience With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
944.01
2,319.06
-1,375.05
-59.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
944.01
2,319.06
-1,375.05
-59.29%
Raw Material Cost
425.33
1,501.61
-1,076.28
-71.68%
Purchase of Finished goods
64.71
4.02
60.69
1,509.70%
(Increase) / Decrease In Stocks
-68.86
-18.53
-50.33
-271.61%
Employee Cost
151.68
248.26
-96.58
-38.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
219.81
314.73
-94.92
-30.16%
Total Expenditure (Excl Depreciation)
792.67
2,050.09
-1,257.42
-61.33%
Operating Profit (PBDIT) excl Other Income
151.34
268.97
-117.63
-43.73%
Other Income
2.66
21.38
-18.72
-87.56%
Operating Profit (PBDIT)
154.00
290.35
-136.35
-46.96%
Interest
36.61
14.55
22.06
151.62%
Exceptional Items
0.00
-11.21
11.21
100.00%
Gross Profit (PBDT)
117.39
264.59
-147.20
-55.63%
Depreciation
30.83
80.23
-49.40
-61.57%
Profit Before Tax
86.55
184.36
-97.81
-53.05%
Tax
22.34
46.72
-24.38
-52.18%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
64.21
137.64
-73.43
-53.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
64.21
137.64
-73.43
-53.35%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
64.21
137.64
-73.43
-53.35%
Equity Capital
10.03
58.71
-48.68
-82.92%
Face Value
1.00
2.00
0.00
Reserves
654.92
1,739.84
-1,084.92
-62.36%
Earnings per share (EPS)
6.40
4.69
1.71
36.46%
Diluted Earnings per share
6.40
4.69
1.71
36.46%
Operating Profit Margin (Excl OI)
16.03%
11.60%
0.00
4.43%
Gross Profit Margin
12.44%
11.41%
0.00
1.03%
PAT Margin
6.80%
5.94%
0.00
0.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 944.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.15% vs 1.63% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 64.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.81% vs -19.14% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.34 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.20% vs -6.70% in Mar 2025

Annual - Interest
Interest 36.61 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.31% vs 59.64% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.03%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025